SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chi-Ming Chu, Cheng-Jueng Chen, De-Chuan Chan, Hurng-Sheng Wu, Yao-Chi Liu, Chen-Yang Shen, Tzu-Ming Chang, Jyh-cherng Yu, Horng-Jyh Harn, Cheng-Ping Yu, Ming-Hsin Yang, CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case–control study based on direct sequencing analysis, World Journal of Surgical Oncology, 2014, 12, 1, 80

    CrossRef

  2. 2
    Shuguang Li, Shanshan Li, Ying Sun, Li Li, The expression of β-catenin in different subtypes of breast cancer and its clinical significance, Tumor Biology, 2014, 35, 8, 7693

    CrossRef

  3. 3
    Siham K. Abunasef, Rana A. El-Beshbishy, The histological changes of the female rat mammary gland during the fertile period with a special reference to E-cadherin expression, The Egyptian Journal of Histology, 2014, 37, 1, 45

    CrossRef

  4. 4
    Hazem Ghebeh, Ghida Sleiman, Pulicat S Manogaran, Amer Al-Mazrou, Eman Barhoush, Falah H Al-Mohanna, Asma Tulbah, Khalid Al-Faqeeh, Chaker N Adra, Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers, BMC Cancer, 2013, 13, 1, 289

    CrossRef

  5. 5
    Hui Pang, Hailing Lu, Hongtao Song, Qingwei Meng, Yanbin Zhao, Na Liu, Fei Lan, Ying Liu, Suhong Yan, Xiaoqun Dong, Li Cai, Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer, Cancer Epidemiology, 2013, 37, 6, 985

    CrossRef

  6. 6
    Kuniaki Ota, Patrick Quint, Ming Ruan, Larry Pederson, Jennifer J. Westendorf, Sundeep Khosla, Merry Jo Oursler, Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization, Journal of Cellular Biochemistry, 2013, 114, 8
  7. 7
    Lisa Y. Pang, Alejandro Cervantes-Arias, Rod W. Else, David J. Argyle, Canine Mammary Cancer Stem Cells are Radio- and Chemo- Resistant and Exhibit an Epithelial-Mesenchymal Transition Phenotype, Cancers, 2011, 3, 4, 1744

    CrossRef

  8. 8
    Felipe C Geyer, Magali Lacroix-Triki, Kay Savage, Monica Arnedos, Maryou B Lambros, Alan MacKay, Rachael Natrajan, Jorge S Reis-Filho, β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation, Modern Pathology, 2011, 24, 2, 209

    CrossRef

  9. 9
    Hyun-Soo Kim, Gou Young Kim, Youn Wha Kim, Yong-Koo Park, Jeong-Yoon Song, Sung-Jig Lim, Stromal CD10 expression and relationship to the E-cadherin/β-catenin complex in breast carcinoma, Histopathology, 2010, 56, 6
  10. 10
    M. Kasper, V. Jaks, M. Fiaschi, R. Toftgard, Hedgehog signalling in breast cancer, Carcinogenesis, 2009, 30, 6, 903

    CrossRef

  11. You have full text access to this Open Access content11
    Aydan Celebiler (Cavusoglu), Yalın Kilic, Serdar Saydam, Tulay Canda, Zuhal Başkan, Ali Ibrahim Sevinc, Meral Sakizli, Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer, Cancer Science, 2009, 100, 12
  12. 12
    Frederick C. Koerner, Diagnostic Problems in Breast Pathology, 2009,

    CrossRef

  13. 13
    Adelina Gama, Joana Paredes, Fátima Gärtner, Anabela Alves, Fernando Schmitt, Expression of E-cadherin, P-cadherin and β-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival, The Veterinary Journal, 2008, 177, 1, 45

    CrossRef

  14. 14
    N. Dumont, M. B. Wilson, Y. G. Crawford, P. A. Reynolds, M. Sigaroudinia, T. D. Tlsty, Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers, Proceedings of the National Academy of Sciences, 2008, 105, 39, 14867

    CrossRef

  15. 15
    AUGUSTO JOSÉ FERREIRA DE MATOS, CÉLIA CRISTINA CARREIRAS LOPES, AUGUSTO MANUEL RODRIGUES FAUSTINO, JÚLIO GIL VALE CARVALHEIRA, GERARD ROEL RUTTEMAN, MARIA DE FÁTIMA RODRIGUES MOUTINHO GÄRTNER, E-cadherin, β-catenin, invasion and lymph node metastases in canine malignant mammary tumours, APMIS, 2007, 115, 4
  16. 16
    DAEHOON PARK, ROLF KÅRESEN, ULRIKA AXCRONA, TOVE NOREN, TORILL SAUER, Expression pattern of adhesion molecules (E-cadherin, α-, β-, γ-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis, APMIS, 2007, 115, 1
  17. 17
    Hiroyuki Toya, Tetsunari Oyama, Susumu Ohwada, Nozomi Togo, Ichiro Sakamoto, Jun Horiguchi, Yukio Koibuchi, Shungo Adachi, Takafumi Jigami, Takashi Nakajima, Tetsu Akiyama, Immunohistochemical expression of the β-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers, Cancer Science, 2007, 98, 4
  18. 18
    P. DURSUN, K. YUCE, A. USUBUTUN, A. AYHAN, Loss of epithelium cadherin expression is associated with reduced overall survival and disease-free survival in early-stage squamous cell cervical carcinoma, International Journal of Gynecological Cancer, 2007, 17, 4
  19. 19
    Bonnie E. Gould Rothberg, Michael B. Bracken, E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis, Breast Cancer Research and Treatment, 2006, 100, 2, 139

    CrossRef

  20. 20
    Zhen Liu, Dong-xu Cui, Bao-lin Liu, Xiao-bo Zhang, Wen-feng Ma, Qiang Zhang, Expression of E-cadherin/catenin complex in breast cancer, Chinese Journal of Cancer Research, 2006, 18, 4, 299

    CrossRef

  21. 21
    Melinda F. Lerwill, The Evolution of Lobular Neoplasia, Advances in Anatomic Pathology, 2006, 13, 4, 157

    CrossRef

  22. 22
    D. Brasanac, I. Boricic, V. Todorovic, N. Tomanovic, S. Radojevic, Cyclin A and β-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin, British Journal of Dermatology, 2005, 153, 6
  23. 23
    Gulisa Turashvili, Jan Bouchal, George Burkadze, Zdenek Kolar, Differentiation of tumours of ductal and lobular origin: ii. proteomics of invasive ductal and lobular breast carcinomas, Biomedical Papers, 2005, 149, 1, 63

    CrossRef

  24. 24
    Eugene M. Howard, Stephen K. Lau, Robert H. Lyles, George G. Birdsong, Jay N. Umbreit, Ruby Kochhar, Expression of e-cadherin in high-risk breast cancer, Journal of Cancer Research and Clinical Oncology, 2005, 131, 1, 14

    CrossRef

  25. 25
    Xiao-feng Tian, Ji-hong Liu, Li-fen Wang, Xiao-Mei Feng, Ji-hong Yao, Expression of survivin and E-cadherin in breast cancer, Chinese Journal of Cancer Research, 2005, 17, 2, 103

    CrossRef

  26. 26
    Zoran Gatalica, Gopalrao Velagaleti, Helena Kuivaniemi, Gerard Tromp, Juan Palazzo, Kerry M. Graves, Michelle Guigneaux, Thomas Wood, Mala Sinha, Bruce Luxon, Gene expression profile of an adenomyoepithelioma of the breast with a reciprocal translocation involving chromosomes 8 and 16, Cancer Genetics and Cytogenetics, 2005, 156, 1, 14

    CrossRef

  27. 27
    Cristina Faleiro-Rodrigues, Isabel MacEdo-Pinto, Deolinda Pereira, Veronica M Ferreira, Carlos S Lopes, Association of E-cadherin and β-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas, Human Pathology, 2004, 35, 6, 663

    CrossRef

  28. 28
    M K Heatley, E-cadherin and catenin expression in normal and neoplastic endocervical glandular epithelium, Histopathology, 2004, 45, 2
  29. 29
    H S Berner, Z Suo, B Risberg, K Villman, M G Karlsson, J M Nesland, Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas, Histopathology, 2003, 42, 6
  30. 30
    Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases, International Journal of Gynecological Cancer, 2003, 13, 6
  31. 31
    Neal S. Goldstein, Does the Level of E-Cadherin Expression Correlate With the Primary Breast Carcinoma Infiltration Pattern and Type of Systemic Metastases?, American Journal of Clinical Pathology, 2002, 118, 3, 425

    CrossRef

  32. 32
    Agnes Bánkfalvi, Melanie Kraßort, Igor B. Buchwalow, Andras Végh, Endre Felszeghy, Jozsef Piffkó, Gains and losses of adhesion molecules (CD44, E-cadherin, and β-catenin) during oral carcinogenesis and tumour progression, The Journal of Pathology, 2002, 198, 3
  33. 33
    Maria Kouvaraki, Vassilis G. Gorgoulis, George Z. Rassidakis, Petros Liodis, Christos Markopoulos, John Gogas, Christos Kittas, High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas, Cancer, 2002, 94, 9
  34. 34
    M. Kawahara, M. Kammori, H. Kanauchi, C. Noguchi, S. Kuramoto, M. Kaminishi, H. Endo, K. Takubo, Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours, European Journal of Surgical Oncology (EJSO), 2002, 28, 2, 140

    CrossRef

  35. 35
    Silvano Costa, Patrizia Terzano, Alessandro Bovicelli, Andrea Martoni, Bruna Angelelli, Donatella Santini, Claudio Ceccarelli, Pertti Lipponen, Mojca Erzén, Stina Syrjänen, Kari Syrjänen, CD44 Isoform 6 (CD44v6) Is a Prognostic Indicator of the Response to Neoadjuvant Chemotherapy in Cervical Carcinoma, Gynecologic Oncology, 2001, 80, 1, 67

    CrossRef

  36. 36
    Neal S. Goldstein, Larry L. Kestin, Frank A. Vicini, Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast, Cancer, 2001, 92, 4
  37. 37
    H Grabsch, S Takeno, T Noguchi, G Hommel, H E Gabbert, W Mueller, Different patterns of β-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome, Histopathology, 2001, 39, 2
  38. 38
    Jian-ming Zheng, Wei-qiang Zheng, Zhi-jin Gong, Ming-hua Zhu, Yi-min Dai, Zhao-huan Zhang, E-cadherin and CD44V6 expresion in human hepatocellular carcinomas, Chinese Journal of Cancer Research, 2001, 13, 4, 284

    CrossRef

  39. 39
    Neal S. Goldstein, MD, Deepa Bassi, MD, Lester J. Layfield, MD, Hadi Yaziji, MD, John C. Watts, MD, Allen M. Gown, MD, E-Cadherin Reactivity of 95 Noninvasive Ductal and Lobular Lesions of the Breast: Implications for the Interpretation of Problematic Lesions, American Journal of Clinical Pathology, 2001, 115, 4, 534

    CrossRef

  40. 40
    Tadahiko Masaki, Akiteru Goto, Masanori Sugiyama, Hiroyoshi Matsuoka, Nobutsugu Abe, Atsuhiko Sakamoto, Yutaka Atomi, Possible contribution of CD44 variant 6 and nuclear β-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma, Cancer, 2001, 92, 10
  41. 41
    C. E. Gillett, D. W. Miles, K. Ryder, D. Skilton, R. D. Liebman, R. J. Springall, D. M. Barnes, A. M. Hanby, Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast, The Journal of Pathology, 2001, 193, 4
  42. 42
    Wen G Jiang, Robert E Mansel, E-cadherin complex and its abnormalities in human breast cancer, Surgical Oncology, 2000, 9, 4, 151

    CrossRef

  43. 43
    Sharmini Ramasami, Keith M. Kerr, Andrea D. Chapman, George King, John S. Cockburn, Robert R. Jeffrey, Expression of CD44v6 but not E-cadherin or β-catenin influences prognosis in primary pulmonary adenocarcinoma, The Journal of Pathology, 2000, 192, 4
  44. 44
    A. Ruibal, J. Schneider, M.a C. del Río, J. Arias, M.I. Núñez, A. Tejerina, La expresión de la molécula de adhesión CD44v6 en carcinomas ductales infiltrantes de mama se asocia con la hormonodependencia. Nuestra experiencia con 168 casos, Revista Española de Medicina Nuclear, 2000, 19, 5, 350

    CrossRef